Table 1.

Demographic and clinical characteristics of study participants.

Parameters	Patients with normal ferritin levels (n = 303)	Patient with abnormal ferritin levels (n = 567)	p-value	Total patients (N = 870)
Agea	50 (30, 64)	57 (45, 65)	0.001b	55.0 (40, 65)
Gender
Male	181 (59.74)	396 (69.84)	0.003c	577
Female	122 (40.26)	171 (30.16)		293
Comorbidities [n (%)]
T2DM	103 (33.99)	284 (50.08)	0.001c	387
HTN	109 (35.97)	272 (47.97)	0.001c	381
IHD	54 (17.82)	98 (17.28)	0.842c	152
CKD	24 (7.92)	83 (14.64)	0.004c	107
COPD	6 (1.98)	19 (3.35)	0.249c	25
Clinical feature [n (%)]
Fever	167 (55.11)	345 (60.85)	0.102c	512
Cough	89 (29.37)	226 (39.86)	0.002c	315
Breathlessness	64 (21.12)	201 (35.25)	0.001c	265
Myalgia	34 (11.22)	77 (13.85)	0.320c	111
Loose stools	32 (10.56)	42 (7.41)	0.112c	74
Sore throat	33 (10.89)	20 (3.53)	0.001c	53
Anosmia	14 (4.42)	27 (4.76)	0.925c	41
Ferritina (ng/ml)	97.3 (52.65–155.5)	545.8 (326.0, 1046.0)	0.001b	315.55 (122.52, 678)
Hba (g/dl)	12.6 (11.45, 14.0)	12.5 (10.6, 14.0)	0.791b	12.55 (10.9, 14.0)
WBCa (x 103/μL)	6200 (4850,8500)	8050 (5800, 12,100)	0.180b	7100 (5300, 10,800)
Plateletsa (Lakhs/ml)	2.15 (1.75, 2.70)	2.19 (1.56, 3.00)	0.817b	2.17 (1.61, 2.91)
ALCa (x 103/μL)	1.33 (0.88, 1.89)	0.94 (0.60, 1.46)	0.390b	1.08 (0.69, 1.65)

^aMedian (Interquartile range).

^bMann Whitney U Test.

^cChi-square Test.